Reuters logo
BRIEF-TPI Enterprises acquires European Opiate pharmaceuticals business
July 12, 2017 / 12:34 AM / 4 months ago

BRIEF-TPI Enterprises acquires European Opiate pharmaceuticals business

July 12 (Reuters) - TPI Enterprises Ltd

* TPE acquires european opiate pharmaceuticals business

* Signed a binding agreement to acquire opiates and tableting division of Vistin Pharma ASA in Norway for A$25.4 million

* Transaction is expected to be eps accretive on a pro-forma npat basis in FY18, in excess of 10 cps

* Acquisition has an implied EBITDA multiple of 5.6x for FY17

* Has conducted an equity offering to raise A$18 million to fund acquisition

* Capital raising was conducted at A$2.20 per share Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below